AKT1 and acute lymphoblastic leukemia: For example, both Notch signaling, which is deregulated in more than 60% of patients with T-ALL (similarly to ~50% of childhood T-ALL, which have activating mutations), and PTEN inactivation (found in more than 10% of patients) [43] can lead to AKT activation [44].